Learning Objectives:

  1. Briefly review biologics' role in escalating costs of cancer care in the United States.
  2. Communicate the design of future studies aimed at using behavioral economics techniques to explore oncologists' prescribing attitudes toward biosimilars.
Session date: 
10/07/2019 - 12:00pm to 1:00pm CDT
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Garth W. Strohbehn, MD, MPhil